Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Meta-Analysis of Relapse Prevention Antidepressant Trials in Depressive Disorders

Glue, Paul, Donovan, Mary Rocco, Kolluri, Sheela, Emir, Birol · 2010 · Australian & New Zealand Journal of Psychiatry

Abstract

Objective: Continuation therapy with antidepressants is recommended for depressed patients who have responded to initial treatment. We quantified its efficacy in preventing relapse of depression in a meta-analysis of 54 double-blind placebo-controlled relapse prevention studies (patient n = 9268). Method: Relapse prevention studies in primary depression and depression subtypes were identified in a systematic literature search. The primary efficacy comparison was relapse rates between active and placebo arms calculated as odds ratios (ORs) using Review Manager version 5.0. Effects of patient age, drug class, diagnostic system and duration of therapy on ORs was examined, along with ORs calculated using different statistical methods. Results: Continuation antidepressants produced robust reduction in relapse (OR = 0.35; 95%CI 0.32–0.39). Pooled ORs were not affected by patient age, drug class, depression subtype or treatment duration, and were similar when calculated by different statistical methods. Patients with primary depression diagnosed by earlier diagnostic systems had slightly lower ORs than those diagnosed using DSM criteria. Conclusions: This meta-analysis emphasizes the importance of continuation treatment following acute response in depressive disorders. The robust findings of relapse prevention designs contrast with acute antidepressant efficacy studies, and may be due to enrichment of the patient population.

Overview

Integrity signals

Registry

Crossref · 10.3109/00048671003705441

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 71 references

Research works printed but not linked: 5

  1. Rouillon F, 1989, Encephale, 15, 527
  2. Lendresse PH, 1985, Psychiatrie Francaise, 16, 156
  3. Robinson DS, 1991, Psychopharmacol Bull, 27, 31
  4. Harrison W, 1986, J Clin Psychiatry, 47, 346
  5. American Psychiatric Association, 1980, Diagnostic and statistical manual of mental disorders

Cited by

See all 113

Metadata

Authors
Glue, P., Donovan, M. R., Kolluri, S., & Emir, B.
Affiliations
  • University of Otago (NZ)
  • The Graduate Center, CUNY (US)
  • Pfizer (United States) (US)
Corresponding author
Glue, Paul
Venue
Australian & New Zealand Journal of Psychiatry
Published
2010-08
Volume
44
Issue
8
Pages
697-705
ISSN
  • 0004-8674 (ISSN-L)
  • 1440-1614
OpenAlex
W2049226284
Cited by
100
References
71
Citations by year
2026: 3 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 8 · 2021: 11 · 2020: 8 · 2019: 10 · 2018: 6 · 2017: 7 · 2016: 4 · 2015: 5 · 2014: 4 · 2013: 2 · 2012: 7
FWCI
0.44
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Australian & New Zealand Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
relapse prevention, depression, relapse rate, antidepressants, primary depression, depression subtypes, diagnostic systems, DSM diagnostic criteria, treatment duration, patient age, comparison of statistical methods
MeSH terms
Clinical Trials as Topic, Depressive Disorder, Humans, Odds Ratio, Treatment Outcome, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Meta-Analysis of Relapse Prevention Antidepressant Trials in Depressive Disorders. https://app.cochat.ai/papers/10.3109/00048671003705441
The paper
Glue, P., Donovan, M. R., Kolluri, S., & Emir, B. (2010). Meta-Analysis of Relapse Prevention Antidepressant Trials in Depressive Disorders. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.3109/00048671003705441

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.